Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Maja Agung Latexindo Tbk. (SURI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Maja Agung Latexindo Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Maja Agung Latexindo Tbk. diperdagangkan di Rp85 (kapitalisasi pasar 538,42 M, volume 24 jam 2,32 jt). Perbedaan utamanya: Maja Agung Latexindo Tbk. jauh lebih besar — sekitar 5,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SURI | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 538,42 M |
Volume | — | 2,32 jt |
Lot | — | 23,25 rb |
Perputaran | — | 195,59 jt |
Harga Rata-rata | — | 84,13 |
Nilai Transaksi | — | 195,59 jt |
Harga Ekuilibrium Indikatif | — | 85 |
Volume Ekuilibrium Indikatif | — | 376 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Maja Agung Latexindo Tbk.
PT Maja Agung Latexindo Tbk (the Company) was established based on Notarial Deed No. 283 dated October 25, 1988 of Benny Kristianto, S.H., notary in Jakarta. The Company started its commercial operations in 1988.
Selengkapnya di halaman SURI →
